BioAge Labs, Inc. (BIOA)
(Delayed Data from NSDQ)
$4.90 USD
-0.32 (-6.13%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.89 -0.01 (-0.20%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BIOA 4.90 -0.32(-6.13%)
Will BIOA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BIOA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BIOA
BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More
BIOA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BIOA
BIOA forms Slingshot Bullish on September 19
BIOA forms Pocket Pivot on September 18
Is BIOA showing upside potential? Crossed Above 200 Day Moving Average shows up after climbing 2.04%
BIOA forms 20 Day Moving Average Support on September 16
BIOA forms 20 Day Moving Average Support on September 15